Pluristem Therapeutics CEO Zami Aberman's 2013 pay rises 11% to $1.7M
Pluristem Therapeutics reports 2013 executive compensation
By ExecPay News
Published: March 31, 2014
Pluristem Therapeutics reported fiscal year 2013 executive compensation information on March 31, 2014.
In 2013, two executives at Pluristem Therapeutics received on average a compensation package of $1.4M, a 13% increase compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chief Executive Officer, received $1.7M in total, which increased by 11% compared to 2012. 65% of Aberman's compensation, or $1.1M, was in stock awards. Aberman also received $75K in bonus, $489K in salary, as well as $21K in other compensation.
Yaky Yanay, Chief Financial Officer, received a compensation package of $1.1M, which increased by 15% compared to previous year. 68% of the compensation package, or $770K, was in stock awards.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on March 31, 2014.